Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,501 GBX | +0.20% |
|
-0.60% | +3.50% |
16/07 | National Advisory Committee On Immunization Recommends RSV Vaccines, Including Arexvy, For Older Adult Populations | RE |
16/07 | GSK: RSV VACCINATION RECOMMENDED FOR CONSIDERATION BY ADULTS AGE… | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.50% | 7.93TCr | |
+61.53% | 85TCr | |
+38.95% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 17TCr |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- European Equities Trading in the US as American Depositary Receipts Appear Set to Close the Week Down Nearly 2%